Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort
: BT is an effective treatment in localized prostate cancer patients, with comparable outcomes and consistent with the OS and BRFS rates reported in the current literature for radical prostatectomy and external beam radiotherapy approaches, and with a reduced frequency of complications. PSA serum levels > 20 ng/mL, GS ≥ 8 and cT stage ≥ T2c can be used as strong predictors of death and/or biochemical recurrence during patients' follow-up.
Authors
- Carlos Rabaça (ORCID: https://orcid.org/0000-0002-3304-3803)
- Domingos Sanchez Roda (ORCID: https://orcid.org/0009-0000-3542-1145)
- Amílcar Sismeiro
- Ricardo Godinho (ORCID: https://orcid.org/0000-0003-3730-7682)
- Guy Antoine Vieira
- Sofia Macedo (ORCID: https://orcid.org/0000-0001-7752-998X)
- José Alberto Pereira
- Bruno J. Pereira
- Mário Lourenço
- Margarida Regencio
Institutions
- University of Beira Interior (PT)
- Instituto Superior Bissaya Barreto (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Hospital da Luz (PT)
- Instituto Português de Oncologia de Coimbra Francisco Gentil (PT)
- University of Coimbra (PT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/jcm15072778
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00